2021 annual financial data
Sagimet Biosciences Inc. - Series A Common Stock 2021 Net margin
Sagimet Biosciences Inc. - Series A Common Stock 2021 net margin with verified…
Direct answer
Net margin was Not calculable.
Operating income was -23,719,000 USD and net income was -24,442,000 USD.
Operating cash flow was -21,710,000 USD.
Get free Sagimet Biosciences Inc. - Series A Common Stock email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -23,719,000 USD
- Net income
- -24,442,000 USD
- Operating cash flow
- -21,710,000 USD
Explore related company data
View all 2021 financial metricsView RevenueView Operating incomeView Net incomeView Operating cash flowView Revenue growthView Operating income growthView Net income growthView Operating cash flow growthView Operating marginView Operating cash flow marginView all Sagimet Biosciences Inc. - Series A Common Stock financial years